News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
593,471 Results
Type
Article (45046)
Company Profile (84)
Press Release (548341)
Multimedia
Podcasts (38)
Webinars (8)
Section
Business (165298)
Career Advice (2516)
Deals (30414)
Drug Delivery (89)
Drug Development (74516)
Employer Resources (144)
FDA (16144)
Job Trends (12987)
News (294303)
Policy (29742)
Tag
Academia (2580)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (82)
Alliances (45129)
ALS (92)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (114)
Approvals (16125)
Artificial intelligence (246)
Autoimmune disease (23)
Automation (13)
Bankruptcy (332)
Best Places to Work (10404)
BIOSECURE Act (20)
Biosimilars (99)
Biotechnology (64)
Bladder cancer (74)
Brain cancer (29)
Breast cancer (273)
Cancer (2200)
Cardiovascular disease (164)
Career advice (2104)
Career pathing (28)
CAR-T (149)
Cell therapy (411)
Cervical cancer (18)
Clinical research (60853)
Collaboration (793)
Company closure (1)
Compensation (254)
Complete response letters (24)
COVID-19 (2415)
CRISPR (36)
C-suite (232)
Cystic fibrosis (100)
Data (2136)
Denatured (12)
Depression (51)
Diabetes (253)
Diagnostics (5687)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (34)
Drug discovery (120)
Drug pricing (100)
Drug shortages (23)
Duchenne muscular dystrophy (93)
Earnings (62147)
Editorial (40)
Employer branding (17)
Employer resources (126)
Events (77195)
Executive appointments (706)
FDA (17412)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (717)
Gene editing (94)
Generative AI (23)
Gene therapy (307)
GLP-1 (647)
Government (3886)
Grass and pollen (5)
Guidances (72)
Healthcare (16574)
Huntington's disease (19)
IgA nephropathy (27)
Immunology and inflammation (111)
Indications (28)
Infectious disease (2559)
Inflammatory bowel disease (130)
Inflation Reduction Act (7)
Influenza (46)
Intellectual property (100)
Interviews (480)
IPO (14059)
IRA (36)
Job creations (2975)
Job search strategy (1740)
Kidney cancer (11)
Labor market (27)
Layoffs (371)
Leadership (21)
Legal (6455)
Liver cancer (75)
Lung cancer (308)
Lymphoma (146)
Machine learning (7)
Management (48)
Manufacturing (275)
MASH (60)
Medical device (11418)
Medtech (11422)
Mergers & acquisitions (16862)
Metabolic disorders (629)
Multiple sclerosis (85)
NASH (17)
Neurodegenerative disease (100)
Neuropsychiatric disorders (28)
Neuroscience (1940)
NextGen: Class of 2025 (5726)
Non-profit (4313)
Now hiring (18)
Obesity (323)
Opinion (230)
Ovarian cancer (73)
Pain (90)
Pancreatic cancer (81)
Parkinson's disease (149)
Partnered (22)
Patents (232)
Patient recruitment (113)
Peanut (44)
People (49319)
Pharmaceutical (27)
Pharmacy benefit managers (15)
Phase I (18912)
Phase II (26834)
Phase III (20148)
Pipeline (1168)
Policy (131)
Postmarket research (2152)
Preclinical (7936)
Press Release (58)
Prostate cancer (100)
Psychedelics (33)
Radiopharmaceuticals (232)
Rare diseases (379)
Real estate (4630)
Recruiting (63)
Regulatory (21468)
Reports (29)
Research institute (2439)
Resumes & cover letters (420)
Rett syndrome (5)
RNA editing (4)
RSV (42)
Schizophrenia (77)
Series A (115)
Series B (77)
Service/supplier (3)
Sickle cell disease (49)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (27)
Startups (3085)
State (2)
Stomach cancer (10)
Supply chain (58)
Tariffs (29)
The Weekly (25)
Vaccines (667)
Venture capitalists (35)
Weight loss (208)
Women's health (29)
Worklife (17)
Date
Today (106)
Last 7 days (785)
Last 30 days (2279)
Last 365 days (29443)
2025 (9827)
2024 (31559)
2023 (35547)
2022 (45755)
2021 (49526)
2020 (48094)
2019 (41349)
2018 (31435)
2017 (29212)
2016 (27743)
2015 (32196)
2014 (24999)
2013 (21124)
2012 (22496)
2011 (23127)
2010 (21665)
Location
Africa (770)
Alabama (49)
Alaska (6)
Arizona (152)
Arkansas (13)
Asia (36735)
Australia (6191)
California (5227)
Canada (1884)
China (494)
Colorado (244)
Connecticut (252)
Delaware (124)
Europe (81858)
Florida (843)
Georgia (169)
Idaho (48)
Illinois (493)
India (24)
Indiana (276)
Iowa (8)
Japan (156)
Kansas (94)
Kentucky (20)
Louisiana (10)
Maine (64)
Maryland (765)
Massachusetts (3803)
Michigan (203)
Minnesota (302)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (24)
Nevada (59)
New Hampshire (60)
New Jersey (1603)
New Mexico (24)
New York (1600)
North Carolina (836)
North Dakota (8)
Northern California (2252)
Ohio (189)
Oklahoma (15)
Oregon (33)
Pennsylvania (1208)
Puerto Rico (13)
Rhode Island (28)
South America (1061)
South Carolina (23)
South Dakota (1)
Southern California (2035)
Tennessee (91)
Texas (829)
United States (20168)
Utah (167)
Virginia (133)
Washington D.C. (56)
Washington State (492)
West Virginia (2)
Wisconsin (46)
593,471 Results for "netherlands institute for neuroscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.
June 14, 2024
·
4 min read
Business
Renowned Alzheimer’s Neurologist Dale Bredesen, MD, Joins Pacific Neuroscience Institute
Pacific Neuroscience Institute® is thrilled to announce that Dale Bredesen, MD, has joined Pacific Neuroscience Institute®.
April 16, 2024
·
5 min read
Press Releases
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
November 5, 2024
·
6 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
Business
LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration
LIXTE Biotechnology Holdings, Inc. announced that it has signed an agreement to expand its collaboration with the Netherlands Cancer Institute and Oncode Institute to study drug synergies of LIXTE’s lead clinical compound, LB-100, with immunotherapy in various cancers.
October 16, 2023
·
5 min read
Press Releases
Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array
April 17, 2025
·
3 min read
1 of 59,348
Next
